Tso P, Yao L, Zheng S, Ee L
Department of Pathology University of Cincinnati, Cincinnati, Ohio, USADivision of Pediatric Gastroenterology-CHMCC, University of Cincinnati, Cincinnati, Ohio, USA.
J Gastroenterol Hepatol. 1998 Nov;13(S3):S270-S274. doi: 10.1111/j.1440-1746.1998.tb01891.x.
Apolipoprotein (apo) A-IV is a protein synthesized, in humans, only by the small intestine. It has a molecular weight of 46 000 Da. This paper summarizes the evidence supporting its role as a satiety factor following the ingestion of fat. This function of apo A-IV is unique and not shared by other apolipoproteins, including apo A-I. The satiety effect of apo A-IV is centrally mediated. The mechanism of how apo A-IV inhibits food intake is not clear but it probably acts by inhibiting both gastric acid secretion as well as gastric motility. Lipid absorption stimulates apo A-IV synthesis and secretion by the jejunum. In addition to lipid feeding, there is evidence that a factor which is released as a result of lipid absorption in the distal small intestine also stimulates the synthesis and release of apo A-IV by the jejunum. This factor is probably PYY.
载脂蛋白(apo)A-IV是一种在人类体内仅由小肠合成的蛋白质。其分子量为46000道尔顿。本文总结了支持其作为脂肪摄入后饱腹感因子作用的证据。载脂蛋白A-IV的这一功能是独特的,其他载脂蛋白(包括载脂蛋白A-I)并不具备。载脂蛋白A-IV的饱腹感效应是由中枢介导的。载脂蛋白A-IV抑制食物摄入的机制尚不清楚,但它可能通过抑制胃酸分泌和胃动力来发挥作用。脂质吸收刺激空肠载脂蛋白A-IV的合成和分泌。除了脂质喂养外,有证据表明,远端小肠脂质吸收释放的一种因子也刺激空肠载脂蛋白A-IV的合成和释放。这种因子可能是肽YY。